PCA
Personal Capital Advisors Portfolio holdings
AUM
$20.6B
1-Year Return
13.65%
This Quarter Return
-16.13%
1 Year Return
-13.65%
3 Year Return
+17.55%
5 Year Return
+33.04%
10 Year Return
–
AUM
$10.1B
AUM Growth
-$1.74B
(-15%)
Cap. Flow
+$463M
Cap. Flow
% of AUM
4.57%
Top 10 Holdings %
Top 10 Hldgs %
45.8%
Holding
415
New
18
Increased
206
Reduced
107
Closed
73
Top Buys
| 1 |
Schwab International Equity ETF
SCHF
|
$103M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$46.9M |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
$37.8M |
| 4 |
Schwab US Broad Market ETF
SCHB
|
$36M |
| 5 |
Sherwin-Williams
SHW
|
$32.9M |
Top Sells
| 1 |
Norfolk Southern
NSC
|
$36.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
$21M |
| 3 |
Marriott International Class A Common Stock
MAR
|
$19.5M |
| 4 |
Apple
AAPL
|
$16.3M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$15.9M |
Sector Composition
| 1 | Technology | 5.1% |
| 2 | Communication Services | 4.1% |
| 3 | Utilities | 4% |
| 4 | Consumer Staples | 3.98% |
| 5 | Healthcare | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Biogen
BIIB
$20.6B
| $255K | ﹤0.01% |
808
-123
| -13% | -$38.8K |
|
302
Diageo
DEO
$61.3B
| $253K | ﹤0.01% |
1,988
-304
| -13% | -$38.7K |
|
303
Novartis
NVS
$251B
| $253K | ﹤0.01% |
3,348
+247
| +8% | +$18.7K |
|
304
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $252K | ﹤0.01% |
2,740
-3,026
| -52% | -$278K |
|
305
Korn Ferry
KFY
$3.83B
| $249K | ﹤0.01% |
10,254
| – | – |
|
306
Cigna
CI
$81.5B
| $248K | ﹤0.01% |
1,399
+73
| +6% | +$12.9K |
|
307
Invesco FTSE RAFI US 1000 ETF
PRF
$8.11B
| $248K | ﹤0.01% |
13,390
-4,790
| -26% | -$88.7K |
|
308
W.R. Berkley
WRB
$27.3B
| $243K | ﹤0.01% |
10,499
-15
| -0.1% | -$347 |
|
309
Yum! Brands
YUM
$40.1B
| $242K | ﹤0.01% |
3,632
-10
| -0.3% | -$666 |
|
310
SPDR S&P Dividend ETF
SDY
$20.5B
| $241K | ﹤0.01% |
3,516
+587
| +20% | +$40.2K |
|
311
Booking.com
BKNG
$178B
| $237K | ﹤0.01% |
176
-23
| -12% | -$31K |
|
312
Schwab US Mid-Cap ETF
SCHM
$12.3B
| $235K | ﹤0.01% |
18,567
+2,220
| +14% | +$28.1K |
|
313
Target
TGT
$42.3B
| $235K | ﹤0.01% |
2,586
-266
| -9% | -$24.2K |
|
314
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.01B
| $234K | ﹤0.01% |
11,718
+773
| +7% | +$15.4K |
|
315
Boston Scientific
BSX
$159B
| $233K | ﹤0.01% |
7,150
-1,869
| -21% | -$60.9K |
|
316
KLA
KLAC
$119B
| $230K | ﹤0.01% |
+1,600
| New | +$230K |
|
317
T-Mobile US
TMUS
$284B
| $230K | ﹤0.01% |
3,216
-1,891
| -37% | -$135K |
|
318
iShares Dow Jones US ETF
IYY
$2.59B
| $229K | ﹤0.01% |
3,638
| – | – |
|
319
Alexandria Real Estate Equities
ARE
$14.5B
| $228K | ﹤0.01% |
1,661
-90
| -5% | -$12.4K |
|
320
Northrop Grumman
NOC
$83.2B
| $227K | ﹤0.01% |
797
+110
| +16% | +$31.3K |
|
321
iShares MSCI USA Momentum Factor ETF
MTUM
$18.2B
| $222K | ﹤0.01% |
2,083
-8
| -0.4% | -$853 |
|
322
Vanguard Intermediate-Term Treasury ETF
VGIT
$32.4B
| $219K | ﹤0.01% |
+3,110
| New | +$219K |
|
323
Invesco S&P 500 Low Volatility ETF
SPLV
$7.99B
| $218K | ﹤0.01% |
4,654
+1,053
| +29% | +$49.3K |
|
324
Carlyle Group
CG
$23.1B
| $216K | ﹤0.01% |
10,000
| – | – |
|
325
Regeneron Pharmaceuticals
REGN
$60.8B
| $213K | ﹤0.01% |
+442
| New | +$213K |
|